Suven Life Sciences Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	-2,763	-1,607	-1,051	-1,183	-1,220
Depreciation & Amortization	56.14	57.92	64.75	65.17	43.7
Other Amortization	-	0.3	0.27	0.26	0.23
Loss (Gain) From Sale of Investments	-95.37	-49.76	-45.49	-17.92	-3.56
Stock-Based Compensation	17.87	12.75	-	-	-
Other Operating Activities	-49.79	-55.45	-192.35	-139.46	-56.52
Change in Accounts Receivable	-1.72	-0.51	-4.79	4.91	4.64
Change in Inventory	1.36	4.71	-7.08	0.22	1.19
Change in Accounts Payable	-6.56	31.59	4.03	-3.22	-10.09
Change in Other Net Operating Assets	-176.35	64.86	76.73	112.9	-35.02
Operating Cash Flow	-3,018	-1,541	-1,155	-1,160	-1,275
Capital Expenditures	-50.83	-372.76	-	-28.95	-197.72
Sale of Property, Plant & Equipment	-	-	24.21	-	-
Investment in Securities	-1,538	1,871	757.32	-2,512	-447.21
Other Investing Activities	-3,032	51.59	162.83	62.64	8.14
Investing Cash Flow	-4,621	1,550	944.36	-2,478	-222.29
Long-Term Debt Repaid	-	-7.1	-8.96	-16.03	-15.55
Total Debt Repaid	-	-7.1	-8.96	-16.03	-15.55
Net Debt Issued (Repaid)	-	-7.1	-8.96	-16.03	-15.55
Issuance of Common Stock	7,572	-	-	3,974	1,476
Other Financing Activities	-	-0.47	-1.58	-2.62	-3.95
Financing Cash Flow	7,572	-7.56	-10.54	3,955	1,457
Miscellaneous Cash Flow Adjustments	-	-	0	-	-
Net Cash Flow	-67.46	0.93	-220.87	317.46	-40.75
Free Cash Flow	-3,069	-1,914	-1,155	-1,189	-1,473
Free Cash Flow Margin	-1458.17%	-2875.39%	-987.51%	-874.42%	-1232.64%
Free Cash Flow Per Share	-13.47	-8.78	-5.29	-6.67	-10.93
Cash Interest Paid	-	0.47	1.58	2.62	3.95
Cash Income Tax Paid	-	-6.05	-61.77	11.02	5.2
Levered Free Cash Flow	-1,945	-1,252	-684.75	-826.32	-616.13
Unlevered Free Cash Flow	-1,945	-1,252	-683.76	-824.52	-612.81
Change in Working Capital	-183.27	100.65	68.89	114.81	-39.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.